Molecular Epidemiology of Global Carbapenemase-Producing <i>Citrobacter</i> spp. (2015

Molecular Epidemiology of Global Carbapenemase-Producing Citrobacter spp. (2015–2017)

Published:2023-04-13 Issue:2 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Nobrega Diego¹^ORCID,Peirano Gisele²³,Matsumura Yasufumi⁴^ORCID,Pitout Johann D. D.²³⁵

Affiliation:

1. Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada

2. Alberta Precision Laboratories, Calgary, Alberta, Canada

3. Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada

4. Kyoto University Graduate School of Medicine, Kyoto, Japan

5. University of Pretoria, Pretoria, South Africa

Abstract

Citrobacter spp. are gaining recognition as important causes of hospital-acquired infections in humans. Among Citrobacter spp., carbapenemase-producing strains are cause of utmost concern to health care services globally due to their ability to resist therapy with virtually any beta-lactam antibiotic.

Funder

Joint Programming Initiative on Antimicrobial Resistance

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.04144-22

Reference36 articles.

1. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance

2. Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017